SEC Form D · filed January 17, 2024
Voyager Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
George A. Scangos · Lexington, MADirectorMichael Higgins · HOUSTON, TXDirectorTodd Carter · Nashville, TNExecJames A. Geraghty · Cambridge, MADirectorGrace A. Colon · Cambridge, MADirectorGlenn A. Pierce · Cambridge, MADirectorSteven A. Hyman · Cambridge, MADirectorPeter Pfreundschuh · Cambridge, MAExecJacquelyn Fahey Sandell · Lexington, MAExecNancy A. Vitale · Cambridge, MADirectorAlfred Sandrock · CAMBRIDGE, MAExec · DirectorRobin Swartz · Lexington, MAExecJude A. Onyia · Cambridge, MADirectorCatherine A. Mackey · Cambridge, MADirectorJames A. Geraghty · LONDON, United KingdomDirectorGrace A. Colon · Cambridge, MADirectorGlenn A. Pierce · Cambridge, MADirectorSteven A. Hyman · Cambridge, MADirectorGeorge A. Scangos · South San Francisco, CADirectorPeter Pfreundschuh · Cambridge, MAExecJacquelyn Fahey Sandell · Lexington, MAExecNancy A. Vitale · Cambridge, MADirectorAlfred Sandrock · CAMBRIDGE, MAExec · DirectorMichael Higgins · London, United KingdomDirectorRobin Swartz · Lexington, MAExecJude A. Onyia · Cambridge, MADirectorCatherine A. Mackey · Cambridge, MADirectorTodd Carter · Nashville, TNExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗